DC Circ. Won't Revisit Revival Of Pharma Terror-Funding Case

By Katie Buehler · February 3, 2023, 6:50 PM EST

The full D.C. Circuit will not review a panel's revival of a lawsuit accusing AstraZeneca Pharmaceuticals LP, Pfizer Inc. and several other pharmaceutical companies of helping finance terror attacks that injured...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Joshua Atchley, et al v. AstraZeneca UK Limited, et al

Case Number

Court

Appellate - DC Circuit

Nature of Suit

3360 Other Personal Injury

Date Filed

August 21, 2020

Recent Articles By Katie

November 06, 2024
An Early Look At Trump's Supreme Court Shortlist
November 01, 2024
Up Next At High Court: Fed Funds And Securities Risks
October 11, 2024
Up Next At High Court: CBD Injuries & The Clean Water Act
October 08, 2024
Jackson, Kagan Target Loper Bright In Ghost Gun Case
October 06, 2024
Top 5 Supreme Court Cases To Watch This Fall
October 04, 2024
Up First At High Court: Civil Rights, Ghost Guns, Atty Fees
August 30, 2024
Vets, Attys Urge Supreme Court To Topple Feres Doctrine
July 05, 2024
High Court Flexes Muscle To Limit Administrative State
June 28, 2024
In Chevron Case, Justices Trade One Unknown For Another
June 26, 2024
Justices Chide 5th Circ. In Biden Social Media Case